ArticleEuropean journal of cancer (Oxford, England : 1990)2012

Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies.

D Mahadevan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.